Construction of Signaling Pathways with RNAi Data and Multiple Reference Networks.

Area of Science:

• Computational biology
• Systems biology
• Bioinformatics

Background:

• Signaling networks are crucial in diseases like cancer, and understanding them is key to developing new treatments.
• Gene knockdown assays, such as RNA interference (RNAi), identify genes in these networks, but determining interactions experimentally is challenging and costly.
• Existing computational methods for signaling network construction from RNAi data often lack scalability or sufficient accuracy.

Purpose of the Study:

• To develop novel, accurate, and scalable computational methods for constructing signaling network topology using RNA interference (RNAi) data.
• To integrate RNAi data with multiple reference signaling networks and phylogenetic trees for improved network inference.
• To address the limitations of previous approaches in terms of scalability and accuracy for large-scale networks.

Main Methods:

• Proposed two new reference-based signaling network construction methods.
• Integrated RNAi data with multiple reference signaling networks and phylogenetic trees.
• Network construction framed as minimizing edit operations on reference networks, weighted by phylogenetic distance.

Main Results:

• The proposed methods demonstrated superior accuracy compared to the state-of-the-art SiNeC method on synthetic, semi-synthetic, and real datasets.
• The methods exhibit good performance even when using evolutionarily distant reference networks.
• Applied to Apoptosis and Wnt pathways, the methods successfully recovered known interactions and suggested novel, testable interactions.

Conclusions:

• The developed methods offer a significant advancement in computational signaling network construction from RNAi data.
• These approaches are accurate, scalable to large networks, and robust to the evolutionary distance of reference networks.
• The findings provide a powerful tool for biological network inference, aiding in the discovery of disease mechanisms and therapeutic targets.